FDA Clears Eyenuk's AI System for Diabetic Retinopathy Screening

By Staff
Tuesday, August 11, 2020 12:27 AM LOS ANGELES—Eyenuk Inc., a global artificial intelligence (AI) medical technology and services company and a leader in real-world applications for AI eye screening, has received the FDA’s 510(k) clearance (K200667) to market its EyeArt autonomous AI System for diabetic retinopathy, a leading cause of blindness among American adults.

Low-Cost Retinal Scanner Could Help Prevent Blindness Worldwide

By Staff
Monday, July 1, 2019 12:18 AM DURHAM, N.C.—Biomedical engineers at Duke University have developed a low-cost, portable optical coherence tomography (OCT) scanner that promises to bring the vision-saving technology to underserved regions throughout the U.S. and abroad. Thanks to a redesigned, 3D-printed spectrometer, the scanner is 15 times lighter and smaller than current commercial systems and is made from parts costing less than a tenth the retail price of commercial systems—all without sacrificing imaging quality. In its first clinical trial, the new OCT scanner produced images of 120 retinas that were 95 percent as sharp as those taken by current commercial systems, which was sufficient for accurate clinical diagnosis, according to Duke.

Remote Possibilities

By Andrew Karp
Monday, June 10, 2019 12:30 AM Many different forms of ocular telemedicine—also referred to as ocular telehealth—have emerged in the past few years. They create a dynamic but fragmented market in which different business models and service offerings compete for consumer dollars and buy-in from eyecare professionals. The proliferation of ocular telehealth options and the growing investment in the category leaves little doubt that it is gaining momentum, VM has learned for this special Megatrend report.

Topcon Appoints Brett Julian as National Sales Manager

By Staff
Tuesday, May 15, 2018 12:18 AM OAKLAND, N.J.—Topcon Medical Systems (TMS), based here, has named Brett Julian as national sales manager. He will be responsible for the management of corporate accounts, reporting to Dawna Owens, director of corporate and government sales.

Carl Zeiss Meditec AG Starts FY 2017/18 With Solid Revenue Growth

By Staff
Wednesday, February 14, 2018 12:18 AM JENA, Germany—Following its strong year-end results, Carl Zeiss Meditec AG (ISIN: DE 0005313704), continued its growth trend in the first quarter of 2017/18. Revenue increased by 5.3 percent, or 9.5 percent with adjusted for currency effects, to €294.7 million, up from €280.0 million in the prior year. Earnings before interest and taxes amounted to €38.9 million; the adjusted EBIT margin was 13.5 percent versus 13.4 percent in the prior year.“Our company remains on course for growth, with encouraging contributions from both strategic business units and all regions,” said Dr. Ludwin Monz, president and CEO of Carl Zeiss Meditec AG. “Targeted investments in refreshing our product portfolio in the areas of ophthalmology and microsurgery and in our global presence are therefore paying off for us.”

Marco’s TRS-5100 Features Programmable Keypad

By Staff
Monday, February 5, 2018 12:11 AM

S.C. Judge Dismisses Opternative Lawsuit Challenging State Law on Online Eye Tests

By Staff
Tuesday, January 30, 2018 12:21 AM COLUMBIA, S.C.—A lawsuit brought here in 2016 by Opternative Inc. challenging the constitutionality of a state law related to telehealth and online refractive eye tests was dismissed by a state court judge late last week. Judge DeAndrea Gist Benjamin of Common Pleas court found that Opternative had “failed to demonstrate that it had standing to bring this claim,” according to the decision filed by the court. The judge’s decision also noted that “South Carolina-licensed ophthalmologists can presumably make their own decisions about whether and how to use—or not use—Opternative’s online technology to assist them in their provision of lawful corrective-lens prescriptions to their patients.”

Aston EyeTech Launches Eyoto, an Ophthalmic Measurement Tech Brand

By Staff
Thursday, January 25, 2018 12:15 AM BIRMINGHAM, U.K.—Aston EyeTech, a U.K.-based developer and manufacturer of ophthalmic measurement technology, is launching Eyoto, a new brand centered around its upcoming next generation eye diagnostic and measurement solutions. The company’s new lens inspection technology, which features the company’s device engineering expertise with advanced intelligent software systems, will be showcased at Vision Expo in March. Aston EyeTech recently completed a $6.7 million Series A investment round. Its Eyoto product portfolio, which will be launched progressively throughout 2018, includes a range of power mapping lensmeters and lens surface inspection tools, binocular autorefractors, and the company’s cloud connected mobile diagnostic platform, which integrates portable hardware, artificial intelligence (AI)-driven diagnostic systems and large-scale data analytics.